BR112023013722A2 - Compostos quadracílicos fundidos, composições e usos dos mesmos - Google Patents
Compostos quadracílicos fundidos, composições e usos dos mesmosInfo
- Publication number
- BR112023013722A2 BR112023013722A2 BR112023013722A BR112023013722A BR112023013722A2 BR 112023013722 A2 BR112023013722 A2 BR 112023013722A2 BR 112023013722 A BR112023013722 A BR 112023013722A BR 112023013722 A BR112023013722 A BR 112023013722A BR 112023013722 A2 BR112023013722 A2 BR 112023013722A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- fused
- compositions
- quadracylic
- substituted fused
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940124789 MK2 inhibitor Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021071062 | 2021-01-11 | ||
| PCT/US2022/011824 WO2022150707A1 (en) | 2021-01-11 | 2022-01-10 | Fused quadracyclic compounds, compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023013722A2 true BR112023013722A2 (pt) | 2024-01-30 |
Family
ID=82356986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023013722A BR112023013722A2 (pt) | 2021-01-11 | 2022-01-10 | Compostos quadracílicos fundidos, composições e usos dos mesmos |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240140958A1 (https=) |
| EP (1) | EP4274833A4 (https=) |
| JP (1) | JP2024504927A (https=) |
| KR (1) | KR20230145335A (https=) |
| CN (1) | CN118574834A (https=) |
| AU (1) | AU2022205678A1 (https=) |
| BR (1) | BR112023013722A2 (https=) |
| CA (1) | CA3204167A1 (https=) |
| IL (1) | IL304142A (https=) |
| MX (1) | MX2023007992A (https=) |
| WO (1) | WO2022150707A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA42543A (fr) | 2015-07-30 | 2018-06-06 | Modernatx Inc | Arn épitope peptidiques concatémériques |
| WO2025219950A1 (en) | 2024-04-18 | 2025-10-23 | Astrazeneca Ab | Small molecule cx3cr1 modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10059718B2 (en) * | 2016-01-04 | 2018-08-28 | Tabomedex Biosciences, LLC | Fused quadracyclic compounds, compositions and uses thereof |
-
2022
- 2022-01-10 US US18/270,616 patent/US20240140958A1/en active Pending
- 2022-01-10 AU AU2022205678A patent/AU2022205678A1/en active Pending
- 2022-01-10 CN CN202280017211.9A patent/CN118574834A/zh active Pending
- 2022-01-10 JP JP2023541723A patent/JP2024504927A/ja active Pending
- 2022-01-10 EP EP22737255.4A patent/EP4274833A4/en active Pending
- 2022-01-10 KR KR1020237026555A patent/KR20230145335A/ko active Pending
- 2022-01-10 CA CA3204167A patent/CA3204167A1/en active Pending
- 2022-01-10 MX MX2023007992A patent/MX2023007992A/es unknown
- 2022-01-10 BR BR112023013722A patent/BR112023013722A2/pt unknown
- 2022-01-10 WO PCT/US2022/011824 patent/WO2022150707A1/en not_active Ceased
-
2023
- 2023-06-29 IL IL304142A patent/IL304142A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3204167A1 (en) | 2022-07-14 |
| EP4274833A1 (en) | 2023-11-15 |
| IL304142A (en) | 2023-09-01 |
| MX2023007992A (es) | 2023-09-27 |
| JP2024504927A (ja) | 2024-02-02 |
| CN118574834A (zh) | 2024-08-30 |
| AU2022205678A1 (en) | 2023-08-03 |
| WO2022150707A1 (en) | 2022-07-14 |
| KR20230145335A (ko) | 2023-10-17 |
| EP4274833A4 (en) | 2025-02-19 |
| US20240140958A1 (en) | 2024-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20200312A (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
| MX389349B (es) | Derivados de ácido borónico y usos terapéuticos de los mismos. | |
| BR112022006977A2 (pt) | Aminas bicíclicas como inibidores de cdk2 | |
| BR112017012342A2 (pt) | compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos | |
| CY1125784T1 (el) | Υποκατεστημενες δικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις της prmt5 | |
| BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
| BR112017026682A2 (pt) | novos compostos bicíclicos como inibidores de dupla ação de atx/ca | |
| BR112017012377A2 (pt) | conjugados anticorpo-fármaco com inibidores de bcl-xl permeáveis à célula | |
| MX2018009645A (es) | Derivados haloalilamina indol y azaindol como inhibidores de lisil-oxidasas y sus usos. | |
| BR112017017727A2 (pt) | heterociclos bicíclicos como inibidores de fgfr4 | |
| BR112023016614A2 (pt) | Inibidores de tyk2 e usos dos mesmos | |
| MX392259B (es) | ANILLOS 6-5 FUSIONADOS COMO INHIBIDORES C5a | |
| BR112015022462A8 (pt) | inibidores de ido, composição farmacêutica, método de inibição de atividade de indolamina 2,3-dioxigenase e uso dos referidos inibidores | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| BR112018072545A2 (pt) | inibidores da arginase e suas aplicações terapêuticas | |
| BR112017022544A2 (pt) | ?composto, composição, e, método para tratamento de infecção por hiv?. | |
| BR112018006034A2 (pt) | compostos bicíclicos como inibidores de atx | |
| BR112018013761A2 (pt) | compostos antiproliferativos e suas composições farmacêuticas e usos | |
| BR112019000589A2 (pt) | pirimidina carboxamidas como inibidores da enzima vanina-1 | |
| CL2021002309A1 (es) | Compuestos útiles en la terapia del vih | |
| MX391392B (es) | ANILLOS 5-5 FUSIONADOS COMO INHIBIDORES C5a. | |
| EA202191114A1 (ru) | Производные пиридинилсульфонамида, фармацевтические композиции и их применение | |
| BR112019004992A2 (pt) | inibição da sinalização de bmp, compostos, composições e usos destes | |
| MX2021004331A (es) | Composiciones estables de semaglutida y usos de las mismas. | |
| CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih |